Gordon Sze, MD
Professor Emeritus of Radiology and Biomedical ImagingCards
About
Research
Publications
2024
Quantifying White Matter Hyperintensity and Brain Volumes in Heterogeneous Clinical and Low-Field Portable MRI
Laso P, Cerri S, Sorby-Adams A, Guo J, Mateen F, Goebl P, Wu J, Liu P, Li H, Young S, Billot B, Puonti O, Sze G, Payabavash S, DeHavenon A, Sheth K, Rosen M, Kirsch J, Strisciuglio N, Wolterink J, Eshaghi A, Barkhof F, Kimberly W, Iglesias J. Quantifying White Matter Hyperintensity and Brain Volumes in Heterogeneous Clinical and Low-Field Portable MRI. 2024, 00: 1-5. DOI: 10.1109/isbi56570.2024.10635502.Peer-Reviewed Original ResearchLow-field, Portable Magnetic Resonance Imaging to Assess Hematoma Volume in Traumatic Brain Injury Patients (P10-5.008)
Zabinska J, Yadlapalli V, Mazurek M, Parasuram N, Lalwani D, Peasley E, Gilmore E, Kim J, Omay S, Sze G, Payabvash S, Sorby-Adams A, Iglesias J, Rosen M, Kimberly W, Sheth K. Low-field, Portable Magnetic Resonance Imaging to Assess Hematoma Volume in Traumatic Brain Injury Patients (P10-5.008). Neurology 2024, 102 DOI: 10.1212/wnl.0000000000208210.Peer-Reviewed Original Research
2021
Low-Field, Portable Magnetic Resonance Imaging at the Bedside to Assess Brain Injury in Patients with Severe COVID-19 (1349)
Mazurek M, Yuen M, Cahn B, Rosen M, Gobeske K, Gilmore E, Hwang D, Kaddouh F, Kim J, Falcone G, Petersen N, Siner J, Spudich S, Sze G, Kimberly W, Sheth K. Low-Field, Portable Magnetic Resonance Imaging at the Bedside to Assess Brain Injury in Patients with Severe COVID-19 (1349). Neurology 2021, 96 DOI: 10.1212/wnl.96.15_supplement.1349.Peer-Reviewed Original Research
2020
Deployment of Portable, Bedside, Low-field Magnetic Resonance Imaging for Evaluation of Stroke Patients (272)
Cahn B, Shah J, Dyvorne H, O’Halloran R, Poole M, Yuen M, Mazurek M, Ward A, Payabvash S, Beekman R, Brown S, Falcone G, Gobeske K, Petersen N, Jasne A, Sharma R, Schindler J, Sansing L, Gilmore E, Wira C, Matouk C, Sze G, Rosen M, Kimberly W, Sheth K. Deployment of Portable, Bedside, Low-field Magnetic Resonance Imaging for Evaluation of Stroke Patients (272). Neurology 2020, 94 DOI: 10.1212/wnl.94.15_supplement.272.Peer-Reviewed Original Research
2017
Apparent Diffusion Coefficient Value Changes and Clinical Correlation in 90 Cases of Cytomegalovirus-Infected Fetuses with Unremarkable Fetal MRI Results
Kotovich D, Guedalia JSB, Hoffmann C, Sze G, Eisenkraft A, Yaniv G. Apparent Diffusion Coefficient Value Changes and Clinical Correlation in 90 Cases of Cytomegalovirus-Infected Fetuses with Unremarkable Fetal MRI Results. American Journal Of Neuroradiology 2017, 38: 1443-1448. PMID: 28522662, PMCID: PMC7959907, DOI: 10.3174/ajnr.a5222.Peer-Reviewed Original ResearchConceptsCytomegalovirus-infected fetusesFetal MRVABS-II scoresADC valuesCytomegalovirus infectionFetal brainApparent diffusion coefficient (ADC) value changesNeurocognitive assessmentIntrauterine cytomegalovirus infectionCase of cytomegalovirusMost brain areasFetal MR imagingVABS-IIDiffuse reductionIntrauterine infectionNeurodevelopmental impairmentClinical findingsBasal gangliaUnremarkable findingsClinical correlationBrain evaluationRetrospective analysisAge control groupTemporal lobeMRI resultsLong Term Outcomes of IV Glyburide In Patients 70 Years of Age or Under: Subgroup Analysis from the Phase II GAMES-RP Study of Patients with Large Hemispheric Infarction (S29.008)
Sheth K, Cheung K, Elm J, Hinson H, Molyneaux B, Beslow L, Sze G, Ostwaldt A, Kimberly W. Long Term Outcomes of IV Glyburide In Patients 70 Years of Age or Under: Subgroup Analysis from the Phase II GAMES-RP Study of Patients with Large Hemispheric Infarction (S29.008). Neurology 2017, 88 DOI: 10.1212/wnl.88.16_supplement.s29.008.Peer-Reviewed Original Research
2016
GAMES (Glyburide Advantage in Malignant Edema and Stroke) RP: A Phase II Study Toward Preventing Edema After Ischemia (I11.006)
Sheth K, Elm J, Hinson H, Molyneaux B, Beslow L, Sze G, Ostwaldt A, Del Zoppo G, Simard J, Jacobson S, Kimberly W. GAMES (Glyburide Advantage in Malignant Edema and Stroke) RP: A Phase II Study Toward Preventing Edema After Ischemia (I11.006). Neurology 2016, 86 DOI: 10.1212/wnl.86.16_supplement.i11.006.Peer-Reviewed Original ResearchGAMES (Glyburide Advantage in Malignant Edema and Stroke) RP Trial: Intermediate Endpoint Analysis as Proof-Of-Concept (I11.010)
Kimberly W, Elm J, Hinson H, Molyneaux B, Beslow L, Sze G, Ostwaldt A, Del Zoppo G, Simard M, Sheth K. GAMES (Glyburide Advantage in Malignant Edema and Stroke) RP Trial: Intermediate Endpoint Analysis as Proof-Of-Concept (I11.010). Neurology 2016, 86 DOI: 10.1212/wnl.86.16_supplement.i11.010.Peer-Reviewed Original ResearchGAMES (Glyburide Advantage in Malignant Edema and Stroke) RP: A Phase II Study Toward Preventing Edema After Ischemia (S7.004)
Sheth K, Elm J, Hinson H, Molyneaux B, Beslow L, Sze G, Ostwaldt A, Del Zoppo G, Simard J, Jacobson S, Kimberly W. GAMES (Glyburide Advantage in Malignant Edema and Stroke) RP: A Phase II Study Toward Preventing Edema After Ischemia (S7.004). Neurology 2016, 86 DOI: 10.1212/wnl.86.16_supplement.s7.004.Peer-Reviewed Original ResearchGAMES (Glyburide Advantage in Malignant Edema and Stroke) RP Trial: Intermediate Endpoint Analysis as Proof-Of-Concept (S7.006)
Kimberly W, Elm J, Hinson H, Molyneaux B, Beslow L, Sze G, Ostwaldt A, Del Zoppo G, Simard M, Sheth K. GAMES (Glyburide Advantage in Malignant Edema and Stroke) RP Trial: Intermediate Endpoint Analysis as Proof-Of-Concept (S7.006). Neurology 2016, 86 DOI: 10.1212/wnl.86.16_supplement.s7.006.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
Clinical Care
Overview
Clinical Specialties
Radiology & Biomedical Imaging; Neuroradiology
Fact Sheets
Cerebral Venous Sinus Thrombosis (CVST)
Learn More on Yale MedicineAcoustic Neuroma
Learn More on Yale MedicinePituitary Tumors
Learn More on Yale MedicineSpondylosis
Learn More on Yale Medicine
Board Certifications
Diagnostic Radiology
- Certification Organization
- AB of Radiology
- Original Certification Date
- 1985
Yale Medicine News
News
News
- May 01, 2023
Connecticut Magazine’s 2023 “Top Doctors” issue recognizes 81 Smilow Cancer Hospital and Yale Cancer Center physicians
- May 03, 2022
Yale Cancer Center and Smilow Cancer Hospital physicians recognized as Connecticut Magazine 'Best Doctors'
- June 02, 2021
Yale Cancer Center and Smilow Cancer Hospital physicians recognized as Connecticut Magazine 'Best Doctors'
- June 04, 2020
Yale Cancer Center and Smilow Cancer Hospital physicians recognized as CT Magazine Best Doctors